心臓ポンプ装置市場レポート：2031年までの動向、予測、競合分析

世界の心臓ポンプ装置市場の将来は、病院と心臓センター市場に機会があると考えられます。心臓ポンプ装置の世界市場は、2025～2031年のCAGRが20.3%で、2031年までに推定80億米ドルに達すると予想されます。この市場の主要促進要因は、肥満の有病率の増加、心臓移植手術におけるこの装置の使用の増加、心血管障害の発生率の上昇です。

• Lucintelの予測によると、タイプ別では、心臓移植の適応がない心不全患者の間でニーズが高まっているため、予測期間中も埋め込み型がより大きなセグメントであり続けるといいます。
• 最終用途カテゴリーでは、手術件数の多さ、心血管疾患の増加、有能な専門医の存在により、病院での心臓ポンプ装置のニーズが高まっているため、病院が引き続き大きなセグメントとなると考えられます。
• 地域別では、人口の心臓病罹患率が高いこと、強固な医療インフラが存在すること、主要企業が存在することから、北米が予測期間中最大の地域であり続けると考えられます。

心臓ポンプ装置市場の戦略的成長機会

心臓ポンプ装置市場に関連するさまざまな用途には、数多くの戦略的成長機会が存在します。これらの機会を理解することは、心血管治療と技術の変化に積極的に参加したい利害関係者にとって重要になります。

• 新興市場への進出：新興市場への進出は、心臓疾患の罹患率の上昇に伴う医療への投資の増加により、優れた成長展望を記載しています。需要が存在する地域向けに費用対効果が高く利用しやすい製品を開発することで、市場の開拓につながる可能性があります。
• デジタルヘルス技術の統合：デジタルヘルス技術を補助人工心臓に統合することで、患者のモニタリングと管理を改善できる可能性があります。遠隔モニタリングにより、機器の機能だけでなく、リアルタイムのデータ分析による臨床結果の向上が可能になり、新たな市場が創出されます。
• 患者中心の設計開発：患者中心の設計に焦点を当てることで、心血管ポンプの普及を促進することができます。患者の快適さ、使いやすさ、生活様式とのシームレスな統合を促進するイノベーションは、需要の主要な推進力となり、患者の治療へのアドヒアランスを高めることができます。
• 生体適合性の開発：生体適合性に優れた心臓ポンプの開発は、新たな成長機会を生み出します。この技術により、合併症が発生する可能性が低くなり、機器の寿命が延びるため、患者にとっても医療提供者にとっても魅力的な機器となり、市場が拡大します。
• パートナーシップとコラボレーション：メーカー、研究機関、医療プロバイダ間の戦略的パートナーシップは、イノベーションと市場参入を加速させています。このような協力関係は、技術の進歩だけでなく、市場の拡大にもつながります。

このような機会は、心臓ポンプ装置市場における成長の有望な未来を明らかにします。利害関係者は、新たな動向と戦略的イニシアチブを活用してイノベーションを創出し、患者の健康状態を改善することで、新たな市場を創出する可能性があります。

心臓ポンプ装置市場の促進要因・課題

心臓ポンプ装置市場の開拓と成長には、さまざまな促進要因・課題が影響します。これらの要素を理解することは、心臓ケア提供における重大な問題に対処しながらこの市場を横断するために不可欠です。

心臓ポンプ装置市場を牽引する要因は以下の通りです。

1.技術の進歩：市場拡大の要因は、生体適合性に優れた次世代LVAD（左心補助循環装置）などの技術進歩です。このような改良により、これらの装置はより優れた性能を発揮するようになり、ユーザー別採用率が高まることで高い需要につながっています。

2.心血管疾患の有病率の上昇：心血管疾患の有病率は世界的に増加しており、その結果、心臓ポンプの市場シェアは世界的に拡大しています。より良い治療を求める患者が増加しているため、先進的心臓ポンプ技術が必要とされています。

3.薬事承認とサポート：新規心臓ポンプ技術に対する支援とともに、規制当局の承認が市場開拓を加速させています。合理化された承認プロセスと相まって、革新的なガジェットのクリニックや病院への導入を迅速化し、治療の選択肢を広げています。

4.研究開発への投資：研究開発費の増加は、革新的な心臓ポンプ技術の成長に寄与しています。このような資金調達は、より効率的で効果的な機器の開発を促進し、市場開拓を後押ししています。

5.認知度の向上と教育：心臓病や先進的アプローチに関する患者や医療従事者の知識の向上が、心血管ポンプの需要増につながっています。患者や医療提供者の理解が深まることが、こうした技術の採用を後押ししています。

心臓ポンプ装置市場における課題は以下の通りです。

1.先進装置の高コスト：先進的心臓ポンプ機器に関連する高コストは、市場成長の課題となっています。高価な技術は、特に医療予算が少ない地域では、アクセシビリティと採用を制限する可能性があります。

2.規制と償還のハードル：この産業が直面する規制や償還のハードルを乗り越えるために、メーカーはしばしば苦労します。複雑な承認プロセスと償還の問題は、市場への参入プロセスを遅らせ、機器の受容率に悪影響を及ぼす可能性があります。

3.機器の合併症と管理：感染症や機器の誤作動などの問題は、心臓ポンプに関連した医療合併症を引き起こし、患者ケアや安全性の問題を圧迫します。これらの問題を解決することは、機器の信頼性とともに臨床転帰を向上させるためにますます重要になってくる。

心臓ポンプ機器市場の開拓や成長には、いくつかの促進要因・課題が影響しています。これらの要因に利害関係者が対処することで、心血管治療の改善に貢献しながら市場をうまく乗り切ることができます。

目次

第1章 エグゼクティブサマリー

第2章 世界の心臓ポンプ装置市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 産業の促進要因と課題

第3章 2019～2031年までの市場動向と予測分析

• マクロ経済動向（2019～2024年）と予測（2025～2031年）
• 世界の心臓ポンプ装置市場の動向（2019～2024年）と予測（2025～2031年）
• 世界の心臓ポンプ装置市場（タイプ別）
  • 埋め込み型心臓ポンプ装置
  • 体外心臓ポンプ装置
• 世界の心臓ポンプ装置市場（製品タイプ別）
  • 心室補助装置（VAD）
  • 全人工心臓（TAH）
  • 大動脈内バルーンポンプ（IABP）
  • 体外膜型人工肺（ECMO）
• 世界の心臓ポンプ装置市場（最終用途別）
  • 病院
  • 心臓センター
  • その他

第4章 2019～2031年までの地域別市場動向と予測分析

• 地域の心臓ポンプ装置市場
• 北米の心臓ポンプ装置市場
• 欧州の心臓ポンプ装置市場
• アジア太平洋の心臓ポンプ装置市場
• その他地域の心臓ポンプ装置市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • タイプによる世界の心臓ポンプ装置市場の成長機会
  • 製品タイプによる世界の心臓ポンプ装置市場の成長機会
  • 最終用途による世界の心臓ポンプ装置市場の成長機会
  • 地域の心臓ポンプ装置市場の成長機会
• 世界の心臓ポンプ装置市場における新たな動向
• 戦略分析
  • 新製品開発
  • 世界の心臓ポンプ装置市場の生産能力拡大
  • 世界の心臓ポンプ装置市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Abbott
• ABIOMED
• CorWave
• LivaNova
• Berlin Heart
• SynCardia Systems
• Jarvik Heart
• BiVACOR
• Leviticus Cardio
• Evaheart

The future of the global heart pump device market looks promising with opportunities in the hospital and cardiac center markets. The global heart pump device market is expected to reach an estimated $8 billion by 2031 with a CAGR of 20.3% from 2025 to 2031. The major drivers for this market are the growing prevalence of obesity, the rising use of this device in heart transplant procedures, and the escalating incidence of cardiovascular disorders.

• Lucintel forecasts that, Within the type category, implanted will remain the larger segment over the forecast period due to its rising need among patients suffering from heart failure who are not eligible for a heart transplant.
• Within the end-use category, hospitals will remain the larger segment due to the increased need for heart pump devices in this setting owing to the number of surgeries being done, growing incidences of cardiovascular disorders, and availability of qualified specialists.
• In terms of regions, North America will remain the largest region over the forecast period due to high heart disease rates among the population, the existence of robust healthcare infrastructure, and the presence of key players in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Heart Pump Device Market

The heart pump device market is evolving with emerging trends that mirror advancements in technology, patient care, and changes within the market itself. Understanding these trends can therefore provide insight into how this industry has changed over time and where it may be headed next in terms of innovative heart pumps.

• Miniaturization of Devices: There is a trend toward miniaturization and efficiency improvement with smaller devices. This can be attributed to advances in materials science and engineering that make procedures less invasive, thus enhancing patients' comfort. Small implants also allow better integration into patients' lives and enable them to move around freely without any hassle.
• Integration with Digital Health: This trend has seen heart pumps integrated into digital health technologies. Remote monitoring along with data analytics has greatly improved device management and patient care. This opens up real-time assessment of both device performance and patient health, thereby leading to prompt actions or targeted curative procedures through such insights.
• Improved Biocompatibility: Advances in material science have led to improved biocompatibility of ventricular assist devices. New materials and coatings have reduced the risks of complications and resulted in better long-term performance of devices. Ensuring biocompatibility is crucial for patient safety and device longevity.
• Focus on Patient-Centric Designs: There has been an increasing focus on designing heart pumps with patients' comfort and lifestyle in mind. These include ergonomic designs, reduced device profiles, and user-friendly interfaces. This trend aims to improve how patients experience healthcare services and their compliance with therapies.
• Expansion into Emerging Markets: The heart pump market is entering emerging markets due to increased healthcare investments and the growing incidence of cardiovascular diseases. In these regions, firms are developing cost-effective solutions that enhance accessibility and affordability concerning heart pump technologies.

These emerging trends are redefining the heart pump device market by improving device functionality, enhancing patient outcomes, and expanding market reach. The shift toward miniaturization, digital integration, or patient-centric design characterizes a broader transformation toward more effective and accessible cardiovascular care.

Recent Developments in the Heart Pump Device Market

In recent times there have been significant advancements within the heart pump device market due to technological advancements made as well as regulatory approvals granted thereby expanding the industry's geographical footprint. Such developments are defining future treatment approaches for cardiovascular complications globally thus leading to improved patient results.

• Next-Generation LVADs: Significant progress has been achieved by introducing next-generation Left Ventricular Assist Devices (LVADs) which are more durable than ever before leading to fewer complications. Through this, these devices offer better clinical outcomes for patients while extending their lifespan addressing key problems concerning HF therapy at hand.
• FDA Approvals for Innovative Designs: Recently FDA-approved new designs for artificial hearts have widened treatment options for many patients who need them across America. Among other things, some innovations include wireless monitoring systems such as those with advanced features like the one that can detect some chemicals contributing to better patient management and care. Emergence of Local Manufacturers:
• In developing markets, local manufacturing has resulted in cheap heart pumps. Such a trend makes advanced cardiovascular technologies more accessible and affordable, particularly for high HF disease burden regions.
• Technological Advances in Biocompatibility: With advancements in materials & coatings, the biocompatibility of artificial hearts is enhanced. New methods are reducing risks of complications and ensuring longer functioning as they are crucial for long-term patient care.
• Increased Investment in R&D: Increased R&D investment stimulates innovation in heart pump technology. Firms are striving to develop more efficient, durable, and patient-friendly units thereby pushing the limits of current artificial heart capabilities.

Through technology enhancement, expanded access or improved patient outcomes, these developments have significantly impacted on heart pump device market. The ongoing advances indicate a commitment towards addressing HF challenge as well as advancing cardiovascular care globally for every individual suffering from it.

Strategic Growth Opportunities for Heart Pump Device Market

The numerous strategic growth opportunities exist within various applications related to heart pump device market. Understanding these opportunities becomes important for stakeholders who want to participate actively in changing landscape of cardiovascular treatment and technology.

• Expansion into Emerging Markets: Going to emerging markets provides excellent growth prospects due to increased investments in healthcare along with higher incidence of cardiac diseases. This can lead to new markets expansion by developing cost effective and accessible products for those areas where demand exists.
• Integration of Digital Health Technologies: There is an opportunity to integrate digital health technologies with ventricular assist devices that could improve patients' monitoring and management. Remote monitoring enables device function as well as better clinical results through real-time data analytics hence creating new marketplaces.
• Patient-Centric Designs Development: A focus on patient-centric designs can encourage the uptake of cardiovascular pumps. Innovations that promote patients' comfort, ease of use, and seamless integration with their way of life can be major drivers of demand and enhance patient adherence to treatment.
• Biocompatibility Developments: Developing heart pumps that have better biocompatibility creates new opportunities for growth. This technology lowers the chance of complications occurring and increases the lifespan of the devices, making them more attractive to patients and providers alike hence creating wider markets.
• Partnerships and Collaborations: Strategic partnerships between manufacturers, research institutions, and healthcare providers can accelerate innovation as well as market entry. These collaborations result in advancement in technologies as well as expansive market coverage.

These opportunities reveal a promising future for growth within the heart pump device market. Stakeholders may utilize emerging trends along with strategic initiatives to create innovations and improve health outcomes for their patients thereby creating new markets.

Heart Pump Device Market Driver and Challenges

Different drivers and challenges influence the development and growth of the heart pump device market. Comprehending these elements is vital to traversing this marketplace while addressing critical problems in cardiac care delivery.

The factors responsible for driving the heart pump device market include:

1. Technological Advancements: Market expansion is caused by technological advancements such as next generation LVADs (Left Ventricular Assist Devices) which have better biocompatibility. Such improvements make these devices perform better thus contributing to increased adoption rates by users leading to high demands.

2. Rising Prevalence of Cardiovascular Diseases: The prevalence of cardiovascular diseases worldwide has grown resulting in increased heart pump market share globally. Increased numbers of patients are seeking better treatments for their lives thus needing advanced heart pumping technologies.

3. Regulatory Approvals and Support: Regulatory approvals together with support for novel heart pump technologies are driving overall market development at an increasing pace. Favorable legislation coupled with streamlined approval processes help quicken introduction of innovative gadgets into clinics or hospitals expanding treatment options.

4. Investment in Research and Development: Rising expenditure on R&D is contributing towards the growth of innovative heart pump technologies. This funding type facilitates the creation of devices that are more efficient and effective thus boosting market development.

5. Growing Awareness and Education: Improved patient as well as health professional knowledge about heart disease and advanced approach has led to increased demand for cardiovascular pumps. Greater understanding among patients and healthcare providers supports the adoption of such technologies.

Challenges in the heart pump device market are:

1. High Costs of Advanced Devices: The high costs associated with advanced heart pump devices pose a challenge for market growth. Expensive technologies can limit accessibility and adoption, particularly in regions with lower healthcare budgets.

2. Regulatory and Reimbursement Hurdles: Manufacturers often struggle to navigate their way through regulatory as well as reimbursement hurdles facing this industry. Complex approval processes coupled with reimbursement issues may slow down the process of entering the market thereby negatively influencing device acceptance rates.

3. Device Complications and Management: Problems like infections or device malfunctioning among others result in medical complications associated with cardiac pumps which then put pressure on patient care and safety issues. Fixing these problems will become increasingly important for enhancing clinical outcomes along with device reliability.

Several drivers or challenges impact the heart pump device market leading to its development or growth. These factors should be addressed by stakeholders so that they successfully navigate across the market while contributing towards improved cardiovascular care.

List of Heart Pump Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies heart pump device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the heart pump device companies profiled in this report include-

• Abbott
• ABIOMED
• CorWave
• LivaNova
• Berlin Heart
• SynCardia Systems
• Jarvik Heart
• BiVACOR
• Leviticus Cardio
• Evaheart

Heart Pump Device by Segment

The study includes a forecast for the global heart pump device market by type, product type, end use, and region.

Heart Pump Device Market by Type [Analysis by Value from 2019 to 2031]:

• Implanted Heart Pump Devices
• Extracorporeal Heart Pump Devices

Heart Pump Device Market by Product Type [Analysis by Value from 2019 to 2031]:

• Ventricular Assist Devices (VADs)
• Total Artificial Hearts (TAHs)
• Intra-Aortic Balloon Pumps (IABPs)
• Extracorporeal Membrane Oxygenation (ECMO)

Heart Pump Device Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Cardiac Centers
• Others

Heart Pump Device Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Heart Pump Device Market

The market for heart pump devices is moving rapidly due to technological breakthroughs and the rise in demand for effective cardiovascular treatment. Significant strides have been made toward innovation and market growth in the U.S., China, Germany, India, and Japan. These improvements are part of a continued effort to combat heart failure and enhance patient outcomes with advanced cardiac devices.

• United States: Recent developments in the U.S. heart pump device market include the FDA's approval of a new generation of Left Ventricular Assist Devices (LVADs) that are more durable and have fewer complications. Innovations from companies like Abbott and Medtronic are leading the way with better integration and remote monitoring capabilities. These improvements aim to enhance patients' quality of life and broaden the use of heart pumps in treating advanced stages of heart failure.
• China: In China, investment in cardiovascular healthcare, coupled with technological advances, has contributed to growth within the heart pump device market. Chinese firms like MicroPort and LifeTech are developing affordable heart pumps tailored to their local markets. Such innovations make it easier for people to access affordable heart pumps, thus helping to control escalating disease burdens.
• Germany: On a European scale, Germany plays a leading role in heart pump technology advancement, with recent innovations focusing on miniature versions that can be implanted beneath a patient's skin. Companies like Berlin Heart and Fresenius are developing new models that guarantee improved patient comfort and longer durability. This development stems from Germany's strong healthcare infrastructure and increased R&D efforts, establishing it as an innovation leader for heart pumps.
• India: The heart pump device market in India is evolving based on affordability and accessibility concerns. Domestic manufacturers are creating cost-effective alternatives for coronary artery disease, which is prevalent among a larger population segment characterized by inadequate access to these devices given its purchasing power parity compared to other countries. The government's approach, along with relationships formed with foreign organizations, has aided in the introduction of modern technologies aimed at advancing care and improving treatment outcomes for patients with cardiac failure.
• Japan: Japan is making strides in heart pump technology with a focus on next-generation devices that offer enhanced biocompatibility and functionality. Compactness, durability, and heart pumps for the elderly population are among the critical concerns pursued by companies like Terumo and Japan Lifeline. These initiatives are improving patient outcomes while widening the application of cardiac support devices for heart failure management.

Features of the Global Heart Pump Device Market

Market Size Estimates: Heart pump device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Heart pump device market size by type, product type, end use, and region in terms of value ($B).

Regional Analysis: Heart pump device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, product types, end uses, and regions for the heart pump device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the heart pump device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the heart pump device market by type (implanted heart pump devices and extracorporeal heart pump devices), product type (ventricular assist devices (VADs), total artificial hearts (TAHs), intra-aortic balloon pumps (IABPs), and extracorporeal membrane oxygenation (ECMO)), end use (hospitals, cardiac centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Heart Pump Device Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Heart Pump Device Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Heart Pump Device Market by Type
  • 3.3.1: Implanted Heart Pump Devices
  • 3.3.2: Extracorporeal Heart Pump Devices
• 3.4: Global Heart Pump Device Market by Product Type
  • 3.4.1: Ventricular Assist Devices (VADs)
  • 3.4.2: Total Artificial Hearts (TAHs)
  • 3.4.3: Intra-Aortic Balloon Pumps (IABPs)
  • 3.4.4: Extracorporeal Membrane Oxygenation (ECMO)
• 3.5: Global Heart Pump Device Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Cardiac Centers
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Heart Pump Device Market by Region
• 4.2: North American Heart Pump Device Market
  • 4.2.1: North American Market by Type: Implanted Heart Pump Devices and Extracorporeal Heart Pump Devices
  • 4.2.2: North American Market by End Use: Hospitals, Cardiac Centers, and Others
• 4.3: European Heart Pump Device Market
  • 4.3.1: European Market by Type: Implanted Heart Pump Devices and Extracorporeal Heart Pump Devices
  • 4.3.2: European Market by End Use: Hospitals, Cardiac Centers, and Others
• 4.4: APAC Heart Pump Device Market
  • 4.4.1: APAC Market by Type: Implanted Heart Pump Devices and Extracorporeal Heart Pump Devices
  • 4.4.2: APAC Market by End Use: Hospitals, Cardiac Centers, and Others
• 4.5: ROW Heart Pump Device Market
  • 4.5.1: ROW Market by Type: Implanted Heart Pump Devices and Extracorporeal Heart Pump Devices
  • 4.5.2: ROW Market by End Use: Hospitals, Cardiac Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Heart Pump Device Market by Type
  • 6.1.2: Growth Opportunities for the Global Heart Pump Device Market by Product Type
  • 6.1.3: Growth Opportunities for the Global Heart Pump Device Market by End Use
  • 6.1.4: Growth Opportunities for the Global Heart Pump Device Market by Region
• 6.2: Emerging Trends in the Global Heart Pump Device Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Heart Pump Device Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Heart Pump Device Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott
• 7.2: ABIOMED
• 7.3: CorWave
• 7.4: LivaNova
• 7.5: Berlin Heart
• 7.6: SynCardia Systems
• 7.7: Jarvik Heart
• 7.8: BiVACOR
• 7.9: Leviticus Cardio
• 7.10: Evaheart